What happened
Congress is considering linking doctor payment rates to medical inflation under the proposed Patients First Act. Update (2026-09-24): STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit. Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand showing many patients remained off of other therapies a…
